NuVasive Eyes Cervical Spine to Drive Future Growth
The company identified the $2.6 billion cervical spine surgery segment as a key growth drive in 2021 and beyond....
Mar 01, 2021,
NuVasive Eyes Cervical Spine to Drive Future Growth
Osseus Fusion Launches Aries-TC Interbody Fusion Device
Aries devices are constructed from highly porous, 3D-printed titanium using PL3XUS, Osseus’ proprietary 3D-printing technology....
Mar 01, 2021,
SeaSpine Launches Reef TLIF Oblique Interbody System
Reef TO accommodates direct impact insertion and insert-and-rotate techniques and offers a reproducible lumbar interbody solution....
Mar 01, 2021,
Aurora Spine Launches SiLO Posterior SI Joint Fusion System
The proprietary SiLO Posterior SI Joint Fusion System was designed specifically for posterior sacroiliac joint fusion....
Mar 01, 2021,
Vericel on Track for Over 30% MACI Growth in 2021
Armed with expanded coverage from UnitedHealthcare, Vericel expects to growth MACI in the low- to mid- +30% range in 2021....
Feb 26, 2021,
Fusion Robotics Gains FDA Clearance for Spinal Navigation & Robotics
Fusion Robotics addresses limitations of current navigation and robotics with greater procedural efficiency at significantly less expense....
Feb 26, 2021,
Empirical Spine Begins PMA Submission for Limiflex Band
The LimiFlex Paraspinous Tension Band is an investigational device designed as an alternative to spinal fusion....
Feb 26, 2021,
NuVasive Acquires Simplify Medical
The company announced it acquired Simplify Medical for $150 million in cash along with future regulatory and sales milestones....
Feb 25, 2021,
Locate Bio’s Chondro3 Graft Granted FDA Breakthrough Device Designation
The biomimetic graft for osteochondral lesions is the company's second Breakthrough Device designation granted in 2021....
Feb 25, 2021,
Medtronic’s Record Mazor Sales Temper Overall Declines
Record Mazor robot sales, combined with near-record imaging and navigation sales, helped MDT offset COVID-related core spine declines....
Feb 24, 2021,
Loading new posts...
No more posts
